Glaxosmithkline | GSK - 流動負債

株価
58.22
毎日の変更
-0.90 -1.52%
毎月
-1.76%
毎年
68.07%
Q2 予測
57.14




流動負債 変化する 日付
AbbVie USD 43.29B 3.9B 2025-12
Amgen USD 25.49B 3.7B 2025-12
AstraZeneca USD 30.62B 3.44B 2025-12
Aurora Cannabis CAD 145.94M 21.82M 2025-12
Bausch Health Companies USD 4.18B 613M 2025-12
Bristol-Myers Squibb USD 28.14B 608M 2025-09
Canopy Growth CAD 98.29M 17.19M 2025-12
Corcept Therapeutics USD 166.08M 6.18M 2025-12
Drreddys Laboratories INR 1.76B 62.5M 2025-12
Eli Lilly USD 35.23B 4.91B 2025-12
GlaxoSmithKline GBP 21.39B 57M 2025-12
Glaxosmithkline GBP 28.82B 144.79M 2025-12
J&J USD 54.13B 3.26B 2025-12
Merck USD 28.63B 2.59B 2025-09
Novartis USD 27.28B 4.72B 2025-12
Pacira USD 120.59M 13.51M 2025-12
Perrigo USD 1.01B 132.4M 2025-12
Pfizer USD 36.6B 1.13B 2025-09
Phibro Animal Health USD 282.37M 12.23M 2025-12
Prestige Brands USD 139.56M 4.95M 2025-12
Roche Holding CHF 28B 421M 2025-12
Sanofi EUR 28.35B 3.76B 2025-12
Supernus Pharmaceuticals USD 338.17M 7.54M 2025-12
Takeda JPY 2.61T 470.53B 2025-12
Teva Pharmaceutical Industries USD 13.46B 1.96B 2025-12
Zoetis USD 2.24B 428M 2025-12